Corcept Therapeutics(us:CORT)
114.58
+109.74%
Updated on 2025-03-31
Open:94.72
Close:114.58
High:117.33
Low:87.58
Prev Close:54.63
Volume:14.26M
Turnover:1.47B
Turnover Ratio:13.51%
Shares:105.50M
MarketCap:12.09B
About Corcept Therapeutics
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company. It engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.
Company Name: Corcept Therapeutics
Address: 149 Commonwealth Drive
Employees: 352
Fiscar Year: 12-31
IPO Date: 2004-04-14
Website: http://www.corcept.com
CIK: 1088856
View all SEC Filings
About
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company. It engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.
Address:149 Commonwealth Drive
Website:http://www.corcept.com
Market Movers